Ann: Trading Halt, page-9

First 9 Last

Share
Profile

Follow
eshmun

11,185 Posts.

2609

12/07/17

19:39

Post #: 25829142
Share

Originally posted by estate09 ↑

SLR reported these numbers from 2010 at Lena. Strange that the resource was considerably higher than what is now reported. Different reporting standards or does this include BOD, Esh??
The Lena deposit
is located in this shear zone and already has a resource of 820,000 tonnes at 8.5 g/t Au
for 224,200 oz over a strike length of 600 metres. This deposit remains open to the north,
south and at depth and is currently subject to a drilling program to the south.

Has MGV thrown anything at Levictus. SLR's 2010 results are from very shallow depths and look pretty exciting

Leviticus Prospect
An initial diamond drilling programme was designed to follow up on historic drill holes at
the “Leviticus” prospect located 2.2 km south of the Lena deposit along the Lena shear
zone (refer to figure 1 for location plan).
The Leviticus prospect is virtually unexplored with only three historic drill holes which
intersected:
3.0 metres at 15.7 g/t Au from 11 metres;
9.0 metres at 3.6 g/t Au from 33 metres; and
3.0 metres at 5.9 g/t Au from 125 metres.
These intersections were recently followed up with two diamond drill holes resulting in
hole 09MODD009 intersecting:
4.8 metres at 26.1 g/t Au from 58 metres; and
3.5 metres at 16.4 g/t Au from 65 metres (refer to table 1 and figure 2).
The next phase of step out drilling in this area will be on 50 metre centres north and
south of the Leviticus prospect.
“The Lena shear zone already hosts a large, high grade deposit at Lena. These latest
results highlight the potential for the similar deposits to be discovered along the 35 km
long shear zone.” said Silver Lake’s Managing Director Les Davis.

Expand

Interesting find in regard SLR reported numbers, I'll take a look tomorrow.

If they can maintain that sort of grade it would be nice. I suspect that to bulk out the ozs the grade will come down. We will find out soon. Esh

MGV Price at posting: 7.9¢ Sentiment: Hold Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

ADD

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

HotCopper Highlights: Your most watched stocks for Week 48, 2024

RSG

Resolute shares bounce back as second payment made to Mali government to secure workers' release

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

There are more pages in this discussion • 1 more message in this thread...

First 9 Last

Add MGV (ASX) to my watchlist

Ann: Trading Halt, page-9

Top Stories

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

HotCopper Highlights: Your most watched stocks for Week 48, 2024

Resolute shares bounce back as second payment made to Mali government to secure workers' release

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game